Cargando…
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report
BACKGROUND: Trastuzumab-related cardiotoxicity has been reported in patients receiving trastuzumab concurrently with other agents, especially with anthracyclines. Cardiac function damage is generally rare, precox and mild with trastuzumab alone. CASE PRESENTATION: We report the case of a 49 year-old...
Autores principales: | Minichillo, Santino, Gallelli, Ilaria, Barbieri, Elena, Cubelli, Marta, Rubino, Daniela, Quercia, Sara, Dall’Olio, Massimo, Rapezzi, Claudio, Zamagni, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678795/ https://www.ncbi.nlm.nih.gov/pubmed/29115937 http://dx.doi.org/10.1186/s12885-017-3712-8 |
Ejemplares similares
-
Trastuzumab Cardiotoxicity in Patients with Breast Cancer
por: Freitas, Aguinaldo Figueiredo, et al.
Publicado: (2014) -
Epigenetic Bases of Aberrant Glycosylation in Cancer
por: Dall’Olio, Fabio, et al.
Publicado: (2017) -
Reduced Representation Libraries from DNA Pools Analysed with Next Generation Semiconductor Based-Sequencing to Identify SNPs in Extreme and Divergent Pigs for Back Fat Thickness
por: Bovo, Samuele, et al.
Publicado: (2015) -
Electrocardiogram Monitoring Wearable Devices and Artificial-Intelligence-Enabled Diagnostic Capabilities: A Review
por: Neri, Luca, et al.
Publicado: (2023) -
Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
por: Marinko, Tanja, et al.
Publicado: (2014)